ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Native valve endocarditis due to Staphylococcus kloosii: a brief report.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnosis of atypical coagulase-negative staphylococci in native valve endocarditis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe the first reported case of native valve endocarditis (NVE) caused by Staphylococcus kloosii and highlight the clinical significance of coagulase-negative staphylococci (CoNS) isolated from blood cultures. We report a case of a 70-year-old male with multiple comorbidities presenting with progressive heart failure, who was managed across three hospitals. Clinical records, imaging findings, and microbiological investigations were reviewed. Retrospective analysis of blood cultures from prior admissions at referring institutions was undertaken. Intra-operative findings during mitral valve replacement revealed vegetations and chordal rupture. S. kloosii was isolated from excised valve tissue after prolonged incubation and confirmed by MALDI-TOF and 16S rRNA sequencing. Blood cultures obtained during earlier admissions at two separate hospitals had also yielded S. kloosii but were interpreted as contaminants. The patient received targeted antimicrobial therapy following surgery and completed a 6-week treatment course, with a favourable outcome despite a drug-related adverse event. This case demonstrates that rare CoNS species such as S. kloosii can cause invasive infection, including NVE. Repeated isolation across multiple healthcare encounters should prompt careful clinical evaluation to avoid delayed diagnosis and improve outcomes.
Indexed as
Identifiers
42426354What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.